188 related articles for article (PubMed ID: 21666070)
1. Homocysteine, B vitamins, and the risk of cardiovascular disease.
Clarke R
Clin Chem; 2011 Aug; 57(8):1201-2. PubMed ID: 21666070
[No Abstract] [Full Text] [Related]
2. [The role of hyper-homocysteinemia in the etiology of some vascular diseases].
Czeizel E; Matos L
Orv Hetil; 1998 Sep; 139(37):2191-6. PubMed ID: 9769688
[TBL] [Abstract][Full Text] [Related]
3. [Hyperhomocysteinemia, a risk factor for atherosclerosis: causes and effects].
Weiss N; Pietrzik K; Keller C
Dtsch Med Wochenschr; 1999 Sep; 124(38):1107-13. PubMed ID: 10535040
[No Abstract] [Full Text] [Related]
4. [Moderate hyperhomocysteinemia: physiopathology of the endothelial lesion and its clinical implications].
Falcón CR; Carreras LO
Sangre (Barc); 1998 Feb; 43(1):47-54. PubMed ID: 9577181
[No Abstract] [Full Text] [Related]
5. Folate and homocysteine.
Young IS; Woodside JV
Curr Opin Clin Nutr Metab Care; 2000 Nov; 3(6):427-32. PubMed ID: 11085827
[TBL] [Abstract][Full Text] [Related]
6. [Vitamin treatments that lower homocysteine concentration: can they decrease cerebrovascular disease in primary prevention?].
Méndez-González J; Rodríguez-Millán E; Julve J; Blanco-Vaca F
Rev Neurol; 2010 Feb 16-28; 50(4):235-44. PubMed ID: 20198596
[TBL] [Abstract][Full Text] [Related]
7. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
[TBL] [Abstract][Full Text] [Related]
8. The controversial role of B-vitamins in cardiovascular risk: An update.
Ntaios G; Savopoulos C; Grekas D; Hatzitolios A
Arch Cardiovasc Dis; 2009 Dec; 102(12):847-54. PubMed ID: 19963194
[TBL] [Abstract][Full Text] [Related]
9. Homocysteine is not so paradoxical.
Klevay LM
Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):e160; author reply e161. PubMed ID: 18799792
[No Abstract] [Full Text] [Related]
10. Prospective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial disease.
Taylor LM; Moneta GL; Sexton GJ; Schuff RA; Porter JM
J Vasc Surg; 1999 Jan; 29(1):8-19; discussion 19-21. PubMed ID: 9925456
[TBL] [Abstract][Full Text] [Related]
11. Homocysteine and cardiovascular risk in patients with diabetes mellitus.
Yeromenko Y; Lavie L; Levy Y
Nutr Metab Cardiovasc Dis; 2001 Apr; 11(2):108-16. PubMed ID: 11434188
[TBL] [Abstract][Full Text] [Related]
12. Homocysteine: evidence for a causal relationship with cardiovascular disease.
Scott CH; Sutton MS
Cardiol Rev; 1999; 7(2):101-7. PubMed ID: 10348972
[TBL] [Abstract][Full Text] [Related]
13. [Disturbances of homocysteine metabolism as a risk factor of cardiovascular diseases development: effect on prognosis and possibilities of correction with drugs].
Shakhmatova OO; Komarov AL; Panchenko EP
Kardiologiia; 2010; 50(1):42-50. PubMed ID: 20144157
[TBL] [Abstract][Full Text] [Related]
14. [Hyperhomocysteinemia in pediatric age and nutritional aspects of folates: an early cardiovascular risk factor].
Caramia G; Belardinelli R
Monaldi Arch Chest Dis; 2006 Dec; 66(4):275-85. PubMed ID: 17312847
[TBL] [Abstract][Full Text] [Related]
15. Homocysteine and vitamins in cardiovascular disease.
Jacobsen DW
Clin Chem; 1998 Aug; 44(8 Pt 2):1833-43. PubMed ID: 9702993
[TBL] [Abstract][Full Text] [Related]
16. Role of homocysteine in age-related vascular and non-vascular diseases.
Parnetti L; Bottiglieri T; Lowenthal D
Aging (Milano); 1997 Aug; 9(4):241-57. PubMed ID: 9359935
[TBL] [Abstract][Full Text] [Related]
17. DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.
Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M;
Clin Chem Lab Med; 2003 Nov; 41(11):1392-403. PubMed ID: 14656016
[TBL] [Abstract][Full Text] [Related]
18. [Hyperhomocysteinemia and cardiometabolic risk].
Vannucchi H; Melo SS
Arq Bras Endocrinol Metabol; 2009 Jul; 53(5):540-9. PubMed ID: 19768245
[TBL] [Abstract][Full Text] [Related]
19. Preventing coronary heart disease: B vitamins and homocysteine.
Omenn GS; Beresford SA; Motulsky AG
Circulation; 1998 Feb; 97(5):421-4. PubMed ID: 9490234
[No Abstract] [Full Text] [Related]
20. Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group.
Robinson K; Arheart K; Refsum H; Brattström L; Boers G; Ueland P; Rubba P; Palma-Reis R; Meleady R; Daly L; Witteman J; Graham I
Circulation; 1998 Feb; 97(5):437-43. PubMed ID: 9490237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
